Fellowship ​

Professor Furness is a leading authority on digestive physiology, especially the neural control of the digestive tract. He has been strongly involved in evaluation of therapeutic drugs and has run clinical trials of candidate drugs. He is currently the leader of a program to develop vagal nerve stimulation for the treatment of inflammatory bowel disease. This is projected for first in human trials in 2018.  He is one of Australia’s most highly cited scientists. He is best known for his work in analysing enteric nerve circuits and for developing the concept of neural chemical coding.

Professor Teede is a clinician, academic, and leader committed to research and translation, delivering measurable changes in policy and practice. She is nationally and internationally recognised for excellence in health and medical research, exceptional leadership, and community engagement. Focusing on improving women’s reproductive health, she has spearheaded the development of the first evidence-based guidelines on PCOS in the world, pioneered interventions for preventing obesity in women, and established one of only four national Diabetes Centres of Excellence. Having raised a family and maintained an active academic and clinical career, she is a role model for women in her profession.

Professor Cameron Simmons is an internationally recognised infectious disease scientist who has made an outstanding contribution to the understanding of dengue. He has been at the forefront of developing and testing novel approaches to improve individual patient outcomes through better diagnosis, prognosis and testing of new treatment options. As Director of Impact Assessment in the Eliminate Dengue Program, he is leading clinical and epidemiological research into Wolbachia for the biocontrol of dengue and Zika. His expertise in the field is recognised through appointments to technical committees at WHO, invitations to international meetings and advisory roles to academic and private sector entities.

Professor Andrew Scott has made significant contributions to science and medicine through the discovery of novel therapeutic antibodies that are impacting on cancer patient outcomes, and the development of evidence for positron emission tomography (PET) that has led to the approval of multiple Medicare clinical indications for accurately staging cancer patients. He has provided leadership of scientific and medical professional organisations and in public education. Professor Scott is recognised Internationally for his research and clinical expertise, and for advocacy of molecular imaging and therapy, reflected by his recent election as President of the World Federation of Nuclear Medicine and Biology.

Stephen Fox is an internationally recognised anatomical and molecular pathologist. He is known for his research in the field of tumour blood vessel formation where he elucidated the mechanism by which a tumour establishes a blood supply that is critical to its growth and spread. He has shown the importance of these in breast tumours and its effect on patient response to treatment. He has developed and implemented novel molecular cancer testing from research to diagnostic laboratories and written several Australian guidelines that has changed the way laboratories test for genetic changes in cancer.